CTLT

Catalent Stock Price

119.81
0.49 (0.41%)
Upgrade to Real-Time
Afterhours (Closed)
119.81

Low
79.65

52 Week Range

High
127.68

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Catalent Inc CTLT NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.49 0.41% 119.81 20:00:00
Open Price Low Price High Price Close Price Prev Close
119.22 119.04 121.11 119.81 119.32
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,930 920,123 $ 120.44 $ 110,819,853 - 79.65 - 127.68
Last Trade Time Type Quantity Stock Price Currency
19:00:00 107,838 $ 119.81 USD

Period:

Draw Mode:

Catalent Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 20.41B 170.34M 130.08M $ 3.09B $ 443.41M 1.14 38.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 3.06k 0.70%

more financials information »

Catalent News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTLT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week115.92121.11110.97116.16578,8063.893.36%
1 Month111.11121.11108.32113.27622,2698.707.83%
3 Months107.00121.1198.73107.14822,62212.8111.97%
6 Months116.91127.6897.86108.73966,2822.902.48%
1 Year88.30127.6879.65100.031,149,76831.5135.69%
3 Years42.65132.2529.2371.031,006,68177.16180.91%
5 Years25.62132.2521.8358.60918,86994.19367.64%

Catalent Description

Catalent Inc is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.


Your Recent History
NYSE
CTLT
Catalent
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.